Welcome to the International Dermatology Outcome Measures
International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.
To become a stakeholder with IDEOM, participation in Delphi survey's, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE
IN THE NEWS
IDEOM Board and Fellows in Washington D.C.
IDEOM Board and Fellows in Washington D.C.
2022 Annual Meeting
Thank you all for attending the 2022 IDEOM annual meeting!
IDEOM President ALICE GOTTLIEB,MD,PHD RECEIVES OUTSTANDING SCIENTIFIC ACHIEVEMENT AWARD BY THE NATIONAL PSORIASIS FOUNDATION
National Psoriasis Foundation has chosen IDEOM Founder and President Dr. Alice Gottlieb to receive the Outstanding Scientific Achievement award for 2021.
Through the NPF Researcher Awards program, NPF honors scientists who have made a unique impact on psoriatic disease research.
The Outstanding Scientific Achievement award recognizes outstanding scientific achievement in psoriatic disease research, taking into consideration independence of thought, originality, significance of discovery, and impact on his/her area of research.
Siegel DM. A commentary on: Patient reported outcome measures in patients undergoing Mohs micrographic surgery: Timing matters.
Available HERE